Documentation centre

Inflammation: the link between abdominal obesity and global cardiometabolic risk (CVD risk)

Relative risk of cardiovascular disease (CVD) associated with the metabolic syndrome of studies included in the meta-analysis of Galassi et al.

Use of hypertriglyceridemic waist as a screening tool to indentifying individuals likely to be characterized by the cluster of abnormalities of the metabolic syndrome

ISA Rome 2006 Symposium Highlights

Risk of coronary heart disease (CHD) in U.S. adults according to subgroups of metabolic syndrome (MS) components

Number of metabolic syndrome abnormalities by NCEP-ATP III clinical criteria, diabetes, and prevalent CVD and hazard ratios of 10-year risk of fatal and non-fatal CVD

Basic illustration of the portal theory

Respective contribution of type 2 diabetic hyperglycemia versus the clustering of abdominal obesity-related risk factors (metabolic syndrome) to the increased coronary heart disease (CHD) risk in diabetes

Age-adjusted prevalence of coronary heart disease (CHD) in the U.S. population over 50 years of age, categorized by presence of metabolic syndrome (MS) and type 2 diabetes

Development of an atherogenic profile associated with menopause-related gain in intra-abdominal adiposity

Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

Circulation 2000;102:179-84

Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report.

Circulation 2002;106:3143-421